期刊
CANCER LETTERS
卷 236, 期 2, 页码 175-185出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2005.04.037
关键词
breast cancer susceptibility gene 1 (BRCA1); transcription; RNA polymerase II; BARD1; estrogen receptor (ER-alpha); ZBRK1
类别
资金
- NCI NIH HHS [R01-CA104546, R01-CA82599] Funding Source: Medline
- NIEHS NIH HHS [R01-ES09169] Funding Source: Medline
BRCA1, a tumor suppressor gene on chromosome 17q21, was identified in 1994 based on its linkage to hereditary breast and ovarian cancer syndromes. The BRCA1 gene encodes a 220 kDa nuclear phosphoprotein. Studies aimed at elucidating the mechanisms of its tumor suppressor activity have revealed, in part, that BRCA1 participates in the DNA damage response and acts to maintain the integrity of the genome. This activity is generic and does not account for the propensity of BRCA1 mutation carriers to develop specific tumor types rather than a broad spectrum of cancers. In addition to genome maintenance, BRCA1 has been found to broadly regulate gene transcription, even though it is not itself a sequence-specific DNA-binding transcription factor. The ability of BRCA1 to function as a coregulator of transcription may underlie some of its tumor suppressor activity and may explain the tissue-specific nature of this activity. This review will focus on how BRCA1 selectively regulates transcription and how this regulatory function may relate to tumor suppression. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据